BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9306129)

  • 1. Fibrinopeptide A, prothrombin fragment 1 + 2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol).
    Sorano GG; Paoletti P; Casciu G; Mameli G; Marongiu F
    Haemostasis; 1997; 27(3):125-30. PubMed ID: 9306129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterization.
    Biancardi M; Cimminiello C; Toschi V; Schiavina G; Regalia F; Casolo F; Bonfardeci G
    Semin Thromb Hemost; 1996; 22 Suppl 1():61-5. PubMed ID: 8807731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
    Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy.
    Rahr HB; Sørensen JV; Larsen JF; Jensen FS; Bredahl C
    Scand J Gastroenterol; 1994 Jun; 29(6):516-21. PubMed ID: 8079109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
    Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J
    Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
    Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical evidence for a relative lack of inhibition of thrombin formation by nonionic contrast media.
    Mamon JF; Hoppensteadt D; Fareed J; Moncada R
    Radiology; 1991 May; 179(2):399-402. PubMed ID: 2014281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
    Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
    Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
    Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
    Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential thrombogenic action of a nonionic radiographic contrast medium used during coronary angiography is offset by heparin during coronary angioplasty.
    Mukherjee M; Scully MF; Thomas M; Jewitt D; Kakkar VV
    Thromb Haemost; 1996 Nov; 76(5):679-81. PubMed ID: 8950772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble, thrombin-related material in arterial thrombi and plasma studied during catheter-directed intra-arterial thrombolysis.
    Sandbaek G; Bjørnsen S; Brosstad F
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):87-91. PubMed ID: 10192657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
    Gando S; Nanzaki S; Sasaki S; Kemmotsu O
    Thromb Haemost; 1998 Jun; 79(6):1111-5. PubMed ID: 9657433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
    Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
    Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin formation and degradation in patients with arteriosclerotic disease.
    Herren T; Stricker H; Haeberli A; Do DD; Straub PW
    Circulation; 1994 Dec; 90(6):2679-86. PubMed ID: 7994808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
    Kario K; Matsuo T; Kodama K; Matsuo M
    Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
    Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
    Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
    Takahashi H; Wada K; Niwano H; Shibata A
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.